Calvenza 03 EIV/EHV (Boehringer-Ingelheim) 10 Dose Vial provides protection from rhinopneumonitis respiratory disease caused by EHV-4 and EHV-1 and all strains of Flu.
Dosage: For initial vaccination, give 2 ml IM, followed by a 2nd dose IM in 3-4 weeks. Administer a third dose 3-4 weeks later either IM or intranasally. Revaccinate annually prior to anticipated exposure. It is a killed virus vaccine that provides protection against rhinopneumonitis respiratory disease caused by Rhino EHV-4 and EHV-1. Also provides immunity against equine flu types A1, A2 And cross-protects against all other equine influenza strains such as the new strains Ohio 2003, Kentucky 2/95 and Newmarket 2/93.
Please do not confuse this vaccine with Calvenza EIV Which only offers protection against Flu or Calvenza EHV which only protects EHV-1 AND EHV-4.